1. Home
  2. List
Reference Patent

Reference - List

When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 54 Hits
  • Search Condition : Filter (MeSH = Melanoma, Experimental / pathology)
Species Resource Title
Human and Animal Cells OP9(RCB1124) , OP9/G-DLL1(RCB2925) In situ delivery of iPSC-derived dendritic cells with local radiotherapy generates systemic antitumor immunity and potentiates PD-L1 blockade in preclinical poorly immunogenic tumor models.
Human and Animal Cells B16 melanoma 4A5(RCB0557) Inhibitory effect of sodium 5,6-benzylidene ascorbate (SBA) on the elevation of melanin biosynthesis induced by ultraviolet-A (UV-A) light in cultured B-16 melanoma cells.
Human and Animal Cells GM95(RCB1026) The absence of functional glucosylceramide synthase does not sensitize melanoma cells for anticancer drugs.
Human and Animal Cells G-361(RCB0991) , SK-MEL-28(RCB1930) , COLO 679(RCB0989) , HMV-II(RCB0777) Actin-binding protein, Espin: a novel metastatic regulator for melanoma.
Human and Animal Cells B16F10(RCB2630) Indomethacin inhibits melanogenesis via down-regulation of Mitf mRNA transcription.
Human and Animal Cells NIH3T3 , WEHI3B Systemic DC Activation Modulates the Tumor Microenvironment and Shapes the Long-Lived Tumor-Specific Memory Mediated by CD8+ T Cells.
Human and Animal Cells LLC(RCB0558) SKAP2 Promotes Podosome Formation to Facilitate Tumor-Associated Macrophage Infiltration and Metastatic Progression.
Human and Animal Cells B16 melanoma(RCB1283) Tokoronin Contained in Dioscorea tokoro Makino ex Miyabe Suppressed α-MSH-Induced Melanogenesis in B16 Cells via Suppression of Classical MAPK Pathway Activation.
Human and Animal Cells B16 melanoma(RCB1283) Melanogenesis Promoting Effect, Antioxidant Activity, and UPLC-ESI-HRMS Characterization of Phenolic Compounds of Argan Leaves Extract.
Human and Animal Cells Jurkat(RCB0806) Selective Targeting of Cancerous Mitochondria and Suppression of Tumor Growth Using Redox-Active Treatment Adjuvant.
Human and Animal Cells B16 melanoma(RCB1283) Glycometabolic Regulation of the Biogenesis of Small Extracellular Vesicles.
Human and Animal Cells MMAc(RCB0808) Galectin-3 Inhibits Cancer Metastasis by Negatively Regulating Integrin β3 Expression.
Human and Animal Cells B16/BL6(RCB2638) Development of DNA-anchored assembly of small extracellular vesicle for efficient antigen delivery to antigen presenting cells.
Human and Animal Cells B16 melanoma 4A5(RCB0557) Anti-proliferative effect of auriculataoside A on B16 melanoma 4A5 cells by suppression of Cdc42-Rac1-RhoA signaling protein levels.
Human and Animal Cells iPS-MEF-Ng-20D-17(APS0001) Generation of Tumor Antigen-Specific Cytotoxic T Lymphocytes from Pluripotent Stem Cells.
Human and Animal Cells LLC(RCB0558) , B16/BL6(RCB2638) Administration of Dendritic Cells and Anti-PD-1 Antibody Converts X-ray Irradiated Tumors Into Effective In situ Vaccines.
Human and Animal Cells B16/BL6(RCB2638) Liposome co-incubation with cancer cells secreted exosomes (extracellular vesicles) with different proteins expressions and different uptake pathways.
Mice RBRC02975 Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells.
Human and Animal Cells B16/BL6(RCB2638) Verification of radiodynamic therapy by medical linear accelerator using a mouse melanoma tumor model.
Human and Animal Cells B16/BL6(RCB2638) Anti-tumor effects of differentiation-inducing factor-1 in malignant melanoma: GSK-3-mediated inhibition of cell proliferation and GSK-3-independent suppression of cell migration and invasion.